CDP: Pulmonary Neoplasms
#1 risk factor of bronchogenic carcinoma - ANS-smoking
13-15% lung cancers - ANS-SCLC
2nd most common organ system affected by carcinoid tumors - ANS-respiratory
biopsy findings in adenocarcinoma NSCLC - ANS-gland formation and mucin
production
bronchoscopy findings in carcinoid tumors - ANS-pink-purple, well vascularized,
pedunculated/sessile central lesions
carcinoid syndrome - ANS-diarrhea, flushing, tachycardia, bronchoconstriction,
hypotension
carcinoid tumors clinical presentation - ANS-most asymptomatic, nonspecific symptoms,
carcinoid syndrome, wheezing, cough, hemoptysis, recurrent pneumonia
carcinoid tumors diagnosis - ANS-bronchoscopy, CT/MRI with contrast, somatostatin
receptor scintigraphy
carcinoid tumors management - ANS-surgical excision, somatostatin analogs to treat
symptoms
carcinoid tumors pathophysiology - ANS-arise from enterochromaffin-like cells in GI and
respiratory that secrete various hormones (serotonin)
CMP findings in SCC NSCLC - ANS-hypercalcemia
common environmental exposure risk factor for bronchogenic carcinoma -
ANS-asbestos, tobacco smoke, radon
CT findings in NSCLC - ANS-atelectatic lung, pleural effusions, mediastinal metastases
CXR findings in SCC NSCLC - ANS-centrally located cavitary lesions and pancoast
tumor
#1 risk factor of bronchogenic carcinoma - ANS-smoking
13-15% lung cancers - ANS-SCLC
2nd most common organ system affected by carcinoid tumors - ANS-respiratory
biopsy findings in adenocarcinoma NSCLC - ANS-gland formation and mucin
production
bronchoscopy findings in carcinoid tumors - ANS-pink-purple, well vascularized,
pedunculated/sessile central lesions
carcinoid syndrome - ANS-diarrhea, flushing, tachycardia, bronchoconstriction,
hypotension
carcinoid tumors clinical presentation - ANS-most asymptomatic, nonspecific symptoms,
carcinoid syndrome, wheezing, cough, hemoptysis, recurrent pneumonia
carcinoid tumors diagnosis - ANS-bronchoscopy, CT/MRI with contrast, somatostatin
receptor scintigraphy
carcinoid tumors management - ANS-surgical excision, somatostatin analogs to treat
symptoms
carcinoid tumors pathophysiology - ANS-arise from enterochromaffin-like cells in GI and
respiratory that secrete various hormones (serotonin)
CMP findings in SCC NSCLC - ANS-hypercalcemia
common environmental exposure risk factor for bronchogenic carcinoma -
ANS-asbestos, tobacco smoke, radon
CT findings in NSCLC - ANS-atelectatic lung, pleural effusions, mediastinal metastases
CXR findings in SCC NSCLC - ANS-centrally located cavitary lesions and pancoast
tumor
